Cornell University’s Life Sciences Technology Innovation Fellowship, formerly known as the BioEntrepreneurship Initiative, enters its second year in 2023-24 with a new cohort of 15 business students and 12 researchers.
Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.
Due to faster decomposition, disposable and plasticized biodegradable medical gowns introduce greenhouse gas discharge problems in landfills, according to new Cornell engineering research.
Researchers sent a menstrual cup to space to test if it was safe for menstruating astronauts to use, which could be especially useful on longer missions to Mars or the moon.
Pfizer and BioNTech have begun a clinical trial for an Omicron-specific Covid-19 vaccine candidate. But Dr. Luis Schang, a virologist at Cornell University, says while it makes sense to develop a specific vaccine against Omicron, we should not lose sight of what is already available.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
Joeva Barrow, assistant professor of molecular nutrition in the Division of Nutritional Sciences, has won a 2022 Hartwell Individual Biomedical Research Award, which funds biomedical research to advance children’s health.
Obesity may spur DNA damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to breast cancer development in this already high-risk group, according to new multi-institutional translational research led by Weill Cornell Medicine scientists.
The National Institute on Aging of the National Institutes of Health has awarded a grant to Weill Cornell Medicine to develop a screening tool and intervention for elder neglect in patients with Alzheimer’s disease and related dementias.
Metal oxide nanoparticles – commonly used as food coloring and anti-caking agents in commercial ingredients – may damage parts of the human intestine, say Cornell and Binghamton University scientists.
